Saneca Pharma Secures Contract Manufacturing Agreement with Xantis Pharma
PTSM: Pharmaceutical Technology Sourcing and Management
CDMO Saneca Pharma has sold registration dossiers for more than 20 pharmaceutical products to Xantis Pharma and will hold an exclusive five-year contract manufacturing agreement for the products with Xantis Pharma.
Saneca Pharma, a contract development and manufacturing organization (CDMO) based in Slovakia, announced that it has sold registration dossiers for more than 20 pharmaceutical products to Swiss company Xantis Pharma as part of an exclusive agreement. The portfolio of products will be marketed by Xantis Pharma throughout Central and Eastern Europe.
Under the terms of the agreement, the European CDMO will hold an exclusive five-year contract manufacturing agreement for the products with Xantis Pharma. Saneca Pharma will continue to act as Xantis Pharma’s agent for out-licensing opportunities for the dossiers outside of these regions.
The two firms have also committed to working together to develop nine new products in the next three years. While Saneca Pharma will use its expertise in formulation development and regulatory support, Xantis Pharma will promote the new offerings to the market.
Source: Saneca Pharma
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
